S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

MERCK Kommanditgesellschaft auf Aktien Stock Forecast, Price & News

+4.70 (+2.92%)
(As of 07/1/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
378,627 shs
Average Volume
Market Capitalization
$21.42 billion
P/E Ratio
Dividend Yield
Price Target

MERCK Kommanditgesellschaft auf Aktien MarketRank™ Forecast

Analyst Rating
Short Interest
Dividend Strength
Based on Four Factors
News Sentiment
Insider Trading
Proj. Earnings Growth

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.64 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive MRK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MERCK Kommanditgesellschaft auf Aktien and its competitors with MarketBeat's FREE daily newsletter.

MERCK Kommanditgesellschaft auf Aktien logo

About MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Stock

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.

MRK Stock News Headlines

UBS stuft MERCK KGAA auf 'Neutral'
Kursverluste für die Aktie von Merck
Treasuries Give Back Ground Amid Optimism About Vaccines
Merck KGaA to Host Earnings Call
MERCK Kommanditgesellschaft auf Aktien (MRKC.SG)
Merck Research Laboratories President bids adieu
Merck (MRK) Presents at ESMO Virtual Congress - Slideshow
Analyst Report: MERCK Kommanditgesellschaft auf Aktien
Merck Vs JNJ, Merck's Got More Magic
See More Headlines

Industry, Sector and Symbol

Drug Manufacturers - Specialty & Generic
Year Founded

Company Calendar

Next Earnings (Estimated)


Pretax Margin


Sales & Book Value

Annual Sales
$20.25 billion
Cash Flow
€3.32 per share
Book Value
€52.61 per share


Free Float
Market Cap
$21.42 billion

MERCK Kommanditgesellschaft auf Aktien Frequently Asked Questions

How has MERCK Kommanditgesellschaft auf Aktien's stock performed in 2022?

MERCK Kommanditgesellschaft auf Aktien's stock was trading at €227.00 at the start of the year. Since then, MRK stock has decreased by 27.0% and is now trading at €165.70.
View the best growth stocks for 2022 here

When is MERCK Kommanditgesellschaft auf Aktien's next earnings date?

MERCK Kommanditgesellschaft auf Aktien is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for MERCK Kommanditgesellschaft auf Aktien

Is MERCK Kommanditgesellschaft auf Aktien a good dividend stock?

MERCK Kommanditgesellschaft auf Aktien(ETR:MRK) pays an annual dividend of €1.85 per share and currently has a dividend yield of 1.12%. The dividend payout ratio of MERCK Kommanditgesellschaft auf Aktien is 25.24%. This payout ratio is at a healthy, sustainable level, below 75%.

Who are MERCK Kommanditgesellschaft auf Aktien's key executives?

MERCK Kommanditgesellschaft auf Aktien's management team includes the following people:
  • Ms. Belen Garijo Lopez M.D., Chair of Exec. Board & CEO (Age 62, Pay $5.47M)
  • Dr. Marcus Kuhnert, CFO & Member of Exec. Board (Age 54, Pay $4.29M)
  • Dr. Kai Beckmann, CEO of Electronics & Member of the Exec. Board (Age 57, Pay $4.31M)
  • Mr. Peter Guenter, CEO of Healthcare Bus. & Member of Exec. Board (Age 60, Pay $2.12M)
  • Dr. Matthias J. Heinzel, CEO of Life Science Sector & Member of Exec. Board (Age 55, Pay $1.61M)
  • Mr. Gerhard Schmitz, Head of Global Accounting (Age 59)
  • Mr. Dirk Toepfer, Chief Information Officer
  • Mr. Constantin Fest, Head of Investor Relations (Age 45)
  • Dr. Friederike Rotsch, Group Gen. Counsel and Head of Group Legal & Compliance (Age 50)
  • Ms. Barbara Weiland, Chief Compliance Officer (Age 48)

What other stocks do shareholders of MERCK Kommanditgesellschaft auf Aktien own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MERCK Kommanditgesellschaft auf Aktien investors own include AbbVie (ABBV), Chevron (CVX), Dynavax Technologies (DVAX), Gilead Sciences (GILD), Eli Lilly and (LLY), Medtronic (MDT), AT&T (T), Adobe (ADBE), Aldeyra Therapeutics (ALDX) and Amgen (AMGN).

What is MERCK Kommanditgesellschaft auf Aktien's stock symbol?

MERCK Kommanditgesellschaft auf Aktien trades on the ETR under the ticker symbol "MRK."

What is MERCK Kommanditgesellschaft auf Aktien's stock price today?

One share of MRK stock can currently be purchased for approximately €165.70.

How much money does MERCK Kommanditgesellschaft auf Aktien make?

MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) has a market capitalization of $21.42 billion and generates $20.25 billion in revenue each year.

How many employees does MERCK Kommanditgesellschaft auf Aktien have?

MERCK Kommanditgesellschaft auf Aktien employs 60,334 workers across the globe.

How can I contact MERCK Kommanditgesellschaft auf Aktien?

MERCK Kommanditgesellschaft auf Aktien's mailing address is 2000 Galloping Hill Rd, Kenilworth, New Jersey 07033-1310. The official website for MERCK Kommanditgesellschaft auf Aktien is www.merckgroup.com. The company can be reached via phone at 49 6151 72 0.

This page (ETR:MRK) was last updated on 7/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.